Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) — Annandale, Virginia

Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) is a clinical research site located in Annandale, Virginia, United States 22003.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Staphylococcal Vaccine, HIV-1-infection, Clostridium Difficile.

Sponsors: Pfizer, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID)?

Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) conducted?

Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) has 3 clinical trials on record, with 1 currently active. Their work covers Staphylococcal Vaccine, HIV-1-infection, Clostridium Difficile.

Is Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) accredited by Crixeo Health?

Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Alliance for Research and Education - Infectious Diseases, LLC (CARE-ID)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.